Read More →
Simply click below to discover how you can take advantage of this. Alan Oscroft | Thursday, 1st October, 2020 | More on: PHP SN See all posts by Alan Oscroft Image source: Getty Images Enter Your Email Address “This Stock Could Be Like Buying Amazon in 1997” Two dividend plus growth shares I’d buy and hold for a decade Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. Our 6 ‘Best Buys Now’ Shares I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. I’m sure you’ll agree that’s quite the statement from Motley Fool Co-Founder Tom Gardner.But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.What’s more, we firmly believe there’s still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.And right now, we’re giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool. Ever since I worked in a business dealing with its products, I’ve liked Smith & Nephew (LSE: SN). The FTSE 100 firm makes replacement joints, with most of its revenues coming from its orthopaedics products. It’s a business that’s led to long-term growth plus dividends.Smith & Nephew is in a highly regulated industry, and has a range of products that are very well regarded by doctors and patients alike.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…To me, that’s a significant defensive moat. But, probably because of it, the shares can sometimes get a bit pricey. Not this year, though, as the Covid-19 slump has pushed the price down 15%. It’s still ahead of the FTSE 100, mind, with the index down 21%. The dividend provides a relatively low yield, but it’s rising steadily.A trading update Thursday revealed a 4% revenue drop in the third quarter. That’s a big improvement over the 29.3% fall for the second quarter, and most of the improvement is in orthopaedics. That’s not surprising, as elective surgery pretty much came to a halt round the world with non-essential medical procedures put on hold.Set for a 2021 comeback?We’ll get full third-quarter details on 29 October, but for now I think the latest news bodes well. Forecasts suggest a small fall back in the dividend this year. But a rebound in forecasts for 2021 suggest we’ll be back to rising annual income. Yields are relatively low at around 2%. But a progressive dividend can be far more valuable in the long run than a short-term higher yield.We’re looking at a forecast 2021 price-to-earnings multiple of around 17.5. I think that’s good value for a FTSE 100 stock with long-term growth potential, and paying progressive dividends.A FTSE 250 dividendA real estate investment trust (REIT) might not sound like a tempting investment in 2020. But Primary Health Properties (LSE: PHP), in the FTSE 250, is a bit different. The company invests in healthcare properties, primarily GP surgeries, and lets them on long-term leases.There’s a lot of defensiveness there. Even if commercial real estate in general is under the cosh, demand for healthcare properties is likely to remain solid. And with increasingly ageing populations in the UK and Ireland, I can only see the demand rising.The Primary Health Properties share price has been one of the most resilient in the FTSE 250 in the face of the pandemic. It dipped relatively lightly in the early lockdown days. And as we enter October, it’s down just 6.5% year-to-date.What stock market crash?Analysts don’t really expect any impact on Primary Health’s profits for the full year, which puts it in an enviable position. The dividend has ben rising nicely over the past few years too, and forecasts have that continuing this year and next.On Thursday, the company confirmed its next quarterly dividend, of 1.475p per share. That’s bang in line with the forecast 5.9p for the full year, which would yield 3.9% on the current share price. I rate it as one of the most reliable dividends in the FTSE 250, and it’s from a stock with long-term growth potential too.I see Primary Health Properties as a very attractive long-term investment, for a goal of providing steady income in retirement. Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended Primary Health Properties. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge!